Recursion Pharmaceuticals, Inc. RXRX Aktienprognose
KI-gestützte Kursvorhersage und Analyse für Recursion Pharmaceuticals, Inc. · Aktualisiert Mär 31, 2026
KI-90-Tage-Prognose
HALTEN
7 Tage
30 Tage
90 Tage
KI-Konfidenz: 3% Spearman-Korrelation
März 31, 2026
Genaues Kursziel für RXRX ansehen
Erstellen Sie ein kostenloses Konto, um KI-Prognosen für über 4.000 Aktien freizuschalten
Kostenlos mit Google anmelden✓ Kostenloses Konto · ✓ 30-Tage-Testversion · ✓ Jederzeit abbrechen
Preisdiagramm
Diagramm wird geladen...
Wichtige Statistiken
Marktkapitalisierung
$1.58B
Kurs-Gewinn-Verhältnis
-4,7x
P/B-Verhältnis
1,40x
EPS
$-1,81
ROE
-162,5%
Nettomarge
-1199,0%
Einnahmen
$74M
Liquidität 3. Grades
7,23x
Verschuldungsgrad
0,10x
Über Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX) ist im Sektor Life Sciences tätig, insbesondere in der Branche Biological Products, (No Diagnostic Substances). Das Unternehmen beschäftigt etwa 515 Mitarbeiter.
Ramon Martin Chavez (born c. 1964) is an American investment banker and entrepreneur. He is vice chairman and partner of Sixth Street Partners. Previously, he served in a variety of senior roles at Goldman Sachs, including chief information officer (2014–2017), chief financial officer, and global co-head of the firm's Securities Division. Marty was also a partner and member of Goldman's management committee. He was the chief technology officer and co-founder of Quorum Software Systems and CEO and co-founder of Kiodex. …
Biological Products, (No Diagnostic Substances) Vergleichbare Unternehmen
| Unternehmen | Ticker | KI-Signal | Marktkapitalisierung | KGV |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $188M | -1,9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $460K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74,1x |
| Alpha Cognition Inc. | ACOG | ██% | $135M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.17B | 14,8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.23B | -4,6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $120M | 1047,3x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0,5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $284M | -1,2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $49M | -19,2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $593M | -1,4x |
| Alvotech | ALVO | ██% | $1.13B | -x |
| Amgen Inc | AMGN | ██% | $190.18B | 24,7x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.77B | -20,5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $46.03B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $378M | -1,0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $165M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $42M | 1,3x |
| Atyr Pharma Inc | ATYR | ██% | $84M | -3,6x |
| Aura Biosciences, Inc. | AURA | ██% | $427M | -4,9x |
| Autolus Therapeutics Plc | AUTL | ██% | $365M | -x |
| Anavex Life Sciences … | AVXL | ██% | $289M | -17,3x |
| Bioatla, Inc. | BCAB | ██% | $11M | -1,1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0,6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $10M | -4,9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.35B | 8,9x |
| Black Diamond Therapeutics, … | BDTX | ██% | $133M | 6,0x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.46B | -12,6x |
| Biogen Inc. | BIIB | ██% | $26.98B | 20,9x |
| Biontech Se | BNTX | ██% | $22.47B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $269M | -1,6x |
| Candel Therapeutics, Inc. | CADL | ██% | $365M | -4,6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $262M | -2,6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3,4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $650K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $840M | -4,1x |
| Compugen Ltd | CGEN | ██% | $208M | 2,9x |
| Cg Oncology, Inc. | CGON | ██% | $5.39B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $79M | -0,5x |
| Coherus Oncology, Inc. | CHRS | ██% | $261M | 1,6x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0,9x |
| Cellectis S.A. | CLLS | ██% | $340M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $968M | -4,8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $110M | -4,0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $156M | -x |
| Curis Inc | CRIS | ██% | $21M | -0,3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.68B | -12,1x |
| Champions Oncology, Inc. | CSBR | ██% | $82M | 32,9x |
| Cel Sci Corp | CVM | ██% | $29M | -0,9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.14B | -3,3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $395M | -13,9x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.07B | -8,7x |
| Precision Biosciences Inc | DTIL | ██% | $137M | -2,2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7,3x |
| Editas Medicine, Inc. | EDIT | ██% | $255M | -0,8x |
| Elutia Inc. | ELUT | ██% | $45M | 0,9x |
| Engene Holdings Inc. | ENGN | ██% | $453M | 3,7x |
| Entera Bio Ltd. | ENTX | ██% | $53M | 8,5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $45M | -3,1x |
| Evaxion A/S | EVAX | ██% | $33M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.56B | 14,8x |
| Exozymes Inc. | EXOZ | ██% | $71M | -x |
| Fate Therapeutics Inc | FATE | ██% | $143M | -1,3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $504M | -3,0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $219M | 1758,3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | 0,5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $174.11B | 20,5x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.37B | 59,5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $45M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.70B | 24,3x |
| Humacyte, Inc. | HUMA | ██% | $131M | -3,3x |
| Immunitybio, Inc. | IBRX | ██% | $7.22B | -3,6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $239M | -1,0x |
| Imagenebio, Inc. | IMA | ██% | $56M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.54B | -x |
| Immatics N.V. | IMTX | ██% | $1.34B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.10B | -14,5x |
| In8bio, Inc. | INAB | ██% | $14M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1,5x |
| Inmune Bio, Inc. | INMB | ██% | $33M | -2,5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2,2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.42B | -4,5x |
| Century Therapeutics, Inc. | IPSC | ██% | $394M | -0,7x |
| Invivyd, Inc. | IVVD | ██% | $375M | -0,4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $22M | -3,2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $136M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.64B | -2,5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.56B | 36,9x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.91B | -17,8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $530M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $387M | -4,7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $293M | -6,7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $7M | -x |
| Leonabio, Inc. | LONA | ██% | $94M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $385M | -0,4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $1.90B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $596M | -3,4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $160M | -x |
| Moderna, Inc. | MRNA | ██% | $20.02B | -3,2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $12.80B | 26,7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $399M | -3,9x |
| Novavax Inc | NVAX | ██% | $1.51B | 3,4x |
| Ocugen, Inc. | OCGN | ██% | $547M | -4,3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0,2x |
| Palisade Bio, Inc. | PALI | ██% | $291M | -0,2x |
| Passage Bio, Inc. | PASG | ██% | $22M | -0,6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.62B | -20,4x |
| Biomx Inc. | PHGE | ██% | $8M | 1,5x |
| Pluri Inc. | PLUR | ██% | $34M | -1,4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $173M | 41,2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | 0,3x |
| Prime Medicine, Inc. | PRME | ██% | $617M | -1,5x |
| Prokidney Corp. | PROK | ██% | $526M | -x |
| Qiagen N.V. | QGEN | ██% | $9.11B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1,7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $602M | -3,8x |
| Repligen Corp | RGEN | ██% | $6.61B | 135,2x |
| Regenxbio Inc. | RGNX | ██% | $418M | -1,8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.84B | -2,0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.08B | -11,1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.58B | -4,7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $273M | 20,6x |
| Sana Biotechnology, Inc. | SANA | ██% | $740M | -2,1x |
| Scilex Holding Co | SCLX | ██% | $47M | -0,4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287,8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $82M | -1,6x |
| Solid Biosciences Inc. | SLDB | ██% | $715M | -0,9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $24M | -1,1x |
| Scholar Rock Holding … | SRRK | ██% | $5.22B | -18,5x |
| Surrozen, Inc./De | SRZN | ██% | $343M | -0,5x |
| Sutro Biopharma, Inc. | STRO | ██% | $356M | -1,0x |
| Protara Therapeutics, Inc. | TARA | ██% | $278M | -2,1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.87B | -12,4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4,6x |
| Bio-Techne Corp | TECH | ██% | $8.20B | 101,1x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $587M | -8,9x |
| Instil Bio, Inc. | TIL | ██% | $56M | -1,1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $159M | -2,5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.26B | -3,0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $17M | -x |
| Twist Bioscience Corp | TWST | ██% | $2.85B | -12,6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $372M | 41,3x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $548M | -x |
| Vericel Corp | VCEL | ██% | $1.61B | 97,7x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2,0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $738M | -0,6x |
| Vaxart, Inc. | VXRT | ██% | $146M | 8,9x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $238M | 570,6x |
| Windtree Therapeutics Inc … | WINT | ██% | $320K | -0,4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $375M | 6,4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $26M | -31,3x |
| Zura Bio Ltd | ZURA | ██% | $565M | -x |
FAQ
-
Ist Recursion Pharmaceuticals, Inc. eine gute Aktie zum Kaufen?
Unsere KI analysiert Recursion Pharmaceuticals, Inc. täglich. Prüfen Sie das Signal oben für die neueste Empfehlung. Führen Sie immer Ihre eigene Recherche durch, bevor Sie investieren.
-
Wie genau sind die Vorhersagen von Recursion Pharmaceuticals, Inc.?
Unsere KI erreicht eine 3% Spearman-Korrelation für diese Aktie, mit durchschnittlich über 67% Genauigkeit bei über 4.000 täglich analysierten Aktien.
-
Wie oft werden die Prognosen aktualisiert?
Recursion Pharmaceuticals, Inc. Prognosen werden täglich mit den neuesten Marktdaten und KI-Modellen aktualisiert.
Bereit, klüger zu investieren?
Schließen Sie sich Tausenden von Anlegern an, die KI-gestützte Aktienprognosen nutzen
Kostenlos anmelden✓ Kostenloses Konto · ✓ Über 4.000 Aktien · ✓ Tägliche Updates
Suchen Sie eine tiefere Analyse von Recursion Pharmaceuticals, Inc.?
Vollständige institutionelle Analyse auf Intratio ansehen →KI-Vorhersagen basieren auf historischen Mustern und sollten nicht die alleinige Grundlage für Investitionsentscheidungen sein. Vergangene Leistungen garantieren keine zukünftigen Ergebnisse. Führen Sie immer Ihre eigene Recherche durch.